Cynara scolymus L. in treatment of hypercholesterolemic type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial

Journal of Medicinal Plants

Volumn 11, Issue 41, 2012, Pages 58-65

  Fallah Huseini, H ^a   Kianbakht, S ^a   Heshmat, R ^b  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Artichoke; Hyperlipidemia; Patient; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTILIPEMIC AGENT; ASPARTATE AMINOTRANSFERASE; CREATININE; CYNARA SCOLYMUS PLANT EXTRACT; GLIBENCLAMIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICHOKE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLANT LEAF; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

CYNARA SCOLYMUS;

EID: 84862842377     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Campbell RK. Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. J. Am. Pharm. Assoc. 2009; 49: S3-S9.
2. Mudaliar S. New frontiers in the management of type 2 diabetes. Indian J. Med. Res. 2007; 125: 275-96. (Pubitemid 46805448)
3. Moon YSK and Kashyap ML. Pharmacologic treatment of type 2 diabetic dyslipidemia. Pharmacother. 2004; 24: 1692-713. (Pubitemid 39578959)
4. Spratt KA. Managing diabetic dyslipidemia: aggressive approach. J. Am. Osteopath. Assoc. 2009; 109: S2-S7.
5. Davidson MH and Toth PP. Comparative effects of lipid-lowering therapies. Prog. Cardiovasc. Dis. 2004; 47: 73-104. (Pubitemid 39600944)
6. Krentz AJ and Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005; 65: 385-411. (Pubitemid 40227460)
7. Huang THW, Kota BP, Razmovski V and Roufogalis BD. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin. Pharmacol. Toxicol. 2005; 96: 3-14. (Pubitemid 40260842)
8. Fugh-Berman A. Herbs and dietary supplements in the prevention and treatment of cardiovascular disease. Prev. Cardiol. 2000; 3: 24-32. (Pubitemid 30217399)
9. Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA and Inge KE. Health benefits of herbs and spices: the past, the present, the future. Med. J. Aust. 2006; 185: S4-24.
10. Low Dog T. A reason to season: the therapeutic benefits of spices and culinary herbs. Explore (NY). 2006; 2: 446-9.
11. st ed. Medical Economics Company. USA. 1998, pp: 793-4.
12. Gebhardt R. Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts. J. Pharmacol. Exp. Ther. 1998; 286: 1122-8. (Pubitemid 29135519)
13. Kucukgergin C, Aydin AF, Ozdemirler-Erata, G, Mehmetcik, G, Kocak-Toker N and Uysal M. Effect of artichoke leaf extract on hepatic and cardiac oxidative stress in rats fed on high cholesterol diet. Biol. Trace Elem. Res. 2010; 135: 264-74.
14. Lupattelli G, Marchesi S, Lombardini R, Roscini AR, Trinca F, Gemelli F, Vaudo G and Mannarino E. Artichoke juice improves endothelial function in hyperlipemia. Life Sci. 2004; 76: 775-82. (Pubitemid 39576151)
15. Heckers H, Dittmar K, Schmahl FW and Huth K. Inefficiency of cynarin as therapeutic regimen in familial type II hyperlipoproteinemia. Atherosclerosis 1977; 26: 249-53. (Pubitemid 8066334)
16. Wider B, Pittler MH, Thompson-Coon J and Ernst E. Artichoke leaf extract for treating hypercholesterolemia. Cochrane Database Syst. Rev. 2009; 4: CD003335.
17. Vinik AL and Jenkins DJ. Dietary fiber in management of diabetes. Diabetes Care. 1988; 11: 160-73.
18. Nazni P, Poongodi Vijayakumar T, Alagianambi P and Amirthaveni M. Hypoglycemic and hypolipidemic effect of Cynara scolymus among selected type 2 diabetic individuals. Pak. J. Nutr. 2006; 5: 147-51. (Pubitemid 44083849)
19. Nomikos T, Detopulou P, Forgopulou E, Pliakis E and Antonopoulou S. Boiled wild artichoke reduces postprandial glycemic and insulinemic responses in normal subjects but has no effect on metabolic syndrome patients. Nutr. Res. 2007; 27: 741-9. (Pubitemid 350153651)
20. Fantini N, Colombo G, Giori A Riva A, Morazzoni P, Bombardelli E and Carai MA. Evidence of glycemia-lowering effect by a Cynara scolymus L. extract in normal and obese rats. Phytother. Res. 2011; 25: 463-6.
21. Ozkan G, Sagdic O, Ekici L, Ozturk I and Ozcan MM. Phenolic compounds of Origanum sipyleum L. extract, and its antioxidant and antibacterial activities. J. Food Lipids 2007; 14: 157-69. (Pubitemid 46994677)
22. Kim DO, Jeong SW and Lee CY. Antioxidant capacity of phenolic phytochemicals from various cultivars of plums. Food Chem. 2003; 81: 321-6. (Pubitemid 36349460)